Improving the accuracy and efficiency of target selection is crucial to addressing the 90% failure rate in clinical drug development.

Our latest infographic utilized Causaly to instantly identify and prioritize targets for Type 2 Diabetes (T2D), zeroing in on mediators by which a target may affect a disease:

• IDENTIFY: Quickly visualize the entire target landscape for T2D, with scientific evidence from 28,000+ documents.
• PRIORITIZE: Refine targets by desired criteria, including novel 2023 targets and clinical trials.
• ASSESS: Explore mechanisms and uncover potential mediators by which a target affects a disease.